Europe Microbial Fermentation Technology Market

Europe Microbial Fermentation Technology Market Size, Share & Industry Trends Analysis Report By Application, By End User (CMOs & CDMOs, Bio-Pharmaceutical Companies, Contract Research Organizations (CROs) and Others), By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-14538 Publication Date: March-2023 Number of Pages: 85
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Microbial Fermentation Technology Market, by Application
1.4.2 Europe Microbial Fermentation Technology Market, by End User
1.4.3 Europe Microbial Fermentation Technology Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Microbial Fermentation Technology Market
Chapter 4. Europe Microbial Fermentation Technology Market by Application
4.1 Europe Antibiotics Market by Country
4.2 Europe Recombinant Proteins Market by Country
4.3 Europe Enzymes Market by Country
4.4 Europe Monoclonal Antibodies Market by Country
4.5 Europe Probiotics Supplements Market by Country
4.6 Europe Vaccines Market by Country
4.7 Europe Biosimilars Market by Country
4.8 Europe Small Molecules Market by Country
4.9 Europe Others Market by Country

Chapter 5. Europe Microbial Fermentation Technology Market by End-user
5.1 Europe CMOs & CDMOs Market by Country
5.2 Europe Bio-Pharmaceutical Companies Market by Country
5.3 Europe Contract Research Organizations (CROs) Market by Country
5.4 Europe Others Market by Country

Chapter 6. Europe Microbial Fermentation Technology Market by Country
6.1 Germany Microbial Fermentation Technology Market
6.1.1 Germany Microbial Fermentation Technology Market by Application
6.1.2 Germany Microbial Fermentation Technology Market by End-user
6.2 UK Microbial Fermentation Technology Market
6.2.1 UK Microbial Fermentation Technology Market by Application
6.2.2 UK Microbial Fermentation Technology Market by End-user
6.3 France Microbial Fermentation Technology Market
6.3.1 France Microbial Fermentation Technology Market by Application
6.3.2 France Microbial Fermentation Technology Market by End-user
6.4 Russia Microbial Fermentation Technology Market
6.4.1 Russia Microbial Fermentation Technology Market by Application
6.4.2 Russia Microbial Fermentation Technology Market by End-user
6.5 Spain Microbial Fermentation Technology Market
6.5.1 Spain Microbial Fermentation Technology Market by Application
6.5.2 Spain Microbial Fermentation Technology Market by End-user
6.6 Italy Microbial Fermentation Technology Market
6.6.1 Italy Microbial Fermentation Technology Market by Application
6.6.2 Italy Microbial Fermentation Technology Market by End-user
6.7 Rest of Europe Microbial Fermentation Technology Market
6.7.1 Rest of Europe Microbial Fermentation Technology Market by Application
6.7.2 Rest of Europe Microbial Fermentation Technology Market by End-user

Chapter 7. Company Profiles
7.1 Biocon Limited
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 BioVectra Inc. (H.I.G. Capital, LLC)
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.2.2.2 Product Launches and Product Expansions:
7.2.2.3 Geographical Expansions:
7.3 Danone S.A.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Category and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Geographical Expansions:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Koninklijke DSM N.V.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition, Joint Venture and Mergers:
7.6 Lonza Group AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Novozymes A/S (Novo Holdings A/S)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.8 Corbion N.V.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
7.9.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo